Abstract
In an examination of Australian plants for substances with antitumor activity, extracts of two botanically related species, Ochrosia moorei and Excavatia coccinea, were tested by the National Cancer Institute, U.S.A. They were found active against several transplantable tumors in mice; the activity was mostly accounted for by two alkaloids, ellipticine and 9-methoxy-ellipticine (Dalton et al, 1967). These alkaloids are widely distributed in the related genera Aspidosperma and Ochrosia. Ellipticine was first identified in extracts of leaves of O. elliptica Labill. (family Apocynaceae), a small tropical evergreen tree (Goodwin et al., 1959); the genus Ochrosia is a member of the tribe Plumiereae along with the alkaloid-producing genus Rauwolfia. Ellipticine and reserpine alkaloids, which are both based on indole, often occur together in the same plant material. Kilminster et al. (1972), in a search for a good botanical source of the alkaloids, extracted ellipticines from various parts of the plant Bleekeria vitiensis, a small tree indigenous to the island of Fiji. Ellipticine itself was not present in the leafy material but occurred in other organs of the plant ; 9-methoxyellipticine was the major alkaloid and occurred in all parts of the plant examined, the bark and wood being an especially rich source. Several chemical syntheses of ellipticines have been devised (see Guthrie et al., 1974 for references).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alazard, R., Boquet, P.L., Paoletti, C: Effects of 9-hydroxyellipticine on growth and macromolecular synthesis in Escherichia coli. FEBS Lett. 63, 278–282 (1976)
Andreé, J., Pfeiffer, A., Rochefort, H.: Inhibition of estrogen-receptor-DNA interaction by intercalating drugs. Biochem. 15, 2964–2969 (1976)
Ansari, B.M., Thompson, E.N.: Methoxy-9-ellipticine in refractory acute myeloid leukemia. Postgrad. Med. J. 51, 103–105 (1975)
Bénard, J., Riou, G.: Effects of 9-hydroxy ellipticine on in vitro transcription of Trypanosoma cruzi DNAs. Biochem. Biophys. Res. Commun. 77, 1189–1195 (1977)
Bhuyan, B.K., Fraser, T.J., Li, L.H.: Cell cycle phase specificity and biochemical effects of ellipticine on mammalian cells. Cancer Res. 32, 2538–2544 (1972)
Branfman, A.R., Bruni, R.J., Reinhold, V.N., Silveira, D., Chadwick, M., Yesair, D.W.: Characterization of the metabolites of ellipticine in rat bile. Drug Metab. Dispos. 6, 542–548 (1978)
Byvoet, P., Sayre, D.: Stimulation of histone methylation by intercalating anti-tumor drugs. Proc. Am. Assoc. Can. Res. 17, 156 (1977)
Chadwick, M., Platz, B.B., Hayes, D., Silveria, D.: Comparative physiological disposition of ellipticine in several animal species after intravenous administration. Drug Metab. Dispos, (in press, 1978)
Chanh, P.H., Sorbara, R., Dat-Xuong, N., Le Pecq, J.B., Paoletti, C: Action cardiovasculaire et toxicite de l’hydroxy-9-ellipticine chez le chien. C.R. Acad. Sci. D. 279, 1039–1043 (1974)
Chanh, P.H., Dat-Xuong, N., Le Pecq, J.B., Paoletti, C.: Cardiovascular activity of 9-hydroxy-ellipticine. Pharmacology 14, 490–498 (1976)
Courseille, P.C., Busetta, B., Hospital, M.: Structure cristalline et moleculaire du dimethyl-5, 11 6H-pyrido[4,3-b] carbazole (ellipticine). Acta Cryst. 30, 2628–2631 (1974)
Cros, S., Sorbara, R., Moisand, Ch., Dat-Xuong, N., Lecointe, P., Paoletti, C: Toxicological and pharmacological studies on 9-hydroxy-ellipticine in mice. Toxicol. Appl. Pharmacol. 33, 484–497 (1975)
Dalton, L.K., Demerac, S., Elmes, B.L., Loder, J.W., Swan, J.M., Teitei, T.: Synthesis of the tumor-inhibitory alkaloids, ellipticine, 9-methoxyellipticine, and related pyrido[4,3-b]carbazoles. Aust. J. Chem. 20, 2715 (1967)
Delbarre, A., Roques, B.P., Le Pecq, J.B., Lallemand, J.Y., Dat-Xuong, N.: PMR studies of the self-association of DNA intercalating ellipticine derivatives in aqueous solution. Biophys. Chem. 4, 275–279 (1976)
Festy, B., Poisson, J., Paoletti, C: A new DNA intercalating drug: methoxy-9-ellipticine. FEBS Lett. 17, 321–323 (1971)
Goodwin, S., Smith, A.F., Horning, E.C.: Alkaloids of ochrosia elliptica labill. J. Am. Chem. Soc. 81, 1903 (1959)
Gosalvez, M., Blanco, M., Hunter, J., Miko, M., Chance, B.: Effects of anticancer agents on the respiration of isolated mitochondria and tumor cells. Eur. J. Cancer 10, 567–574 (1974)
Guthrie, R.W., Brossi, A., Mennona, F.A., Mullin, J.G., Kierstead, R.W.: Ellipticine derivatives. J. Chem. 18, 755–760 (1974)
Hansch, C: Commentary: strategy in drug design. Cancer Chemother. Rep. 56, 433–441 (1972)
Hardesty, C.T., Chaney, N.A., Mead, J.A.R.: The effect of route of administration on the distribution of ellipticine in mice. Cancer Res. 32, 1884–1889 (1972)
Hayat, M., Mathe, G., Janot, M.M., Potier, P., Dat-Xuong, N., Cave, A., Sevenet, T., Kan-Fan, C., Poisson, J., Miet, J., Le Men, J., Le Goffic, F., Gouyette, A., Ahond, A., Dalton, L.K., Connors, T.A.: Experimental screening of 3 forms and 19 derivatives or analogs of ellipticine: oncostatic effect on L1210 leukemia and immunosuppressive effect of 4 of them. Biomedicine 21, 101–106 (1974)
Herman, E., Vick, J., Burka, B.: The cardiovascular actions of ellipticine. Toxicol. Appl. Pharmacol. 18, 743–751 (1971)
Herman, E.H., Chadwick, D.P., Mhatre, R.M.: Comparison of the acute hemolytic and cardiovascular actions of ellipticine (NSC-71795) and some ellipticine analogs. Cancer Chemother. Rep. 58, 637–642 (1974)
Juret, P., Tanguy, A., Girard, A., Le Talaer, J.Y., Dat-Xuong, N., Le Pecq, J.B., Paoletti, C.: Preliminary trial of 9-hydroxy-2-methylellipticinium (NSC 264-137) in advanced human cancers. Eur. J. Can. (in press, 1977)
Kann, H.E., Jr., Kohn, K.W.: Effects of deoxyribonucleic acid-reactive drugs on ribonucleic acid synthesis in leukemia L1210 cells. Mol. Pharmacol. 8, 551–560 (1972)
Kilminster, K.N., Sainsbury, M., Webb, B.: Alkaloids and terpenoids of bleekevia vitiensis. Phytochemistry 11, 389 (1972)
Kohn, K.W., Snyder, A.L., Kann, H.E., Jr.: Size distributions of high molecular weight RNA synthesized by L1210 cells: effects of DNA-reactive drugs. Biochim. Biophys. Acta 324, 93–109 (1973)
Kohn, K.W., Waring, M.J., Glaubiger, D., Friedman, C.A.: Intercalative binding of ellipticine to DNA. Cancer Res. 35, 71–76 (1975)
Lee, I.P.: A possible mechanism of ellipticine-induced hemolysis. J. Pharmacol. Exp. Ther. 196, 525–535 (1976)
Le Pecq, J.B., Dat-Xuong, N., Goose, C., Paoletti, C.: A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs. Proc. Natl. Acad. Sci. USA 71, 5078–5082 (1974a)
Le Pecq, J.B., LeBret, M., Goose, Ch., Paoletti, C.: Interest of quantum mechanical calculations for the design of anticancerous drugs in the series of ellipticines. In: Molecular and quantum pharmacology. Bergmann, E., Pullman, B. (eds.), pp. 515–535. Dordecht-Holland: D. Reidel 1974 b
Le Pecq, J.B., Goose, C., Dat-Xuong, N., Cros, S., Paoletti, C.: Antitumor activity of 9-hydroxyellipticine (NSC 210717) on L1210 mouse leukemia and the effect of route of injection. Cancer Res. 36, 3067–3076 (1976)
Lerman, L.S.: Structural considerations in the interaction of DNA and acridines. J. Mol. Biol. 3, 18 (1961)
Lesca, P., Lecointe, P., Paoletti, C., Mansuy, D.: Induction des mono-oxygenases heatiques par l’ellipticine chez le rat: formation de cytochrome P488 activite hydroxylante. C.R. Acad. Sci. D 282, 1457–1460 (1976)
Lesca, P., Lecointe, P., Paoletti, C.: The hydroxylation of the antitumor agent, ellipticine, by liver microsomes from differently pretreated rats. Biochem. Pharmacol. 27, 1203–1209 (1978)
Li, L.H., Cowie, C.H.: Biochemical effects of ellipticine leukemia L1210 cells. Biochim. Biophys. Acta 353, 375–384(1974)
Liau, M.C., Lin, G.W., Knight, C.A., Huribert, R.B.: Inhibition of RNA methylation by intercalating agents. Cancer Res. 37, 4202–4210 (1977)
Mathe, G., Hayat, M., De Vassal, F., Schwatzenberg, L., Schneider, J.R., Schlumberger, C., Jasmin, C., Rosenfeld, C.: Methoxy 9-ellipticine lactate III. Clinical screening: its action in acute myeloblastic leukemia. Rev. Eur. Etud. Clin. Biol. 15, 541 (1970)
Müller, W., Crothers, D.M.: Studies of the binding of actinomycin and related compounds to DNA. Eur. J. Biochem. 35, 251–290 (1968)
Müller, W., Crothers, D.M.: Interactions of heteroaromatic compounds with nucleic acids. 1. The influence of heteroatoms and polarizability on the base specificity of intercalating ligands. Eur. J. Biochem. 54, 267–277 (1975)
Mullin, J.G., Kierstead, R.W., Grunberg, E.: Ellipticine derivatives. J. Med. Chem. 18, 755–760 (1975)
Paoletti, C., Le Pecq, J.B., Dat-Xuong, N., Lesca, P., Lecointe, P.: New anticancer derivatives in the ellipticine series. Proc. 10th Int. Cancer Congr. (in press, 1977)
Reinhold, V.N., Bruni, R.J.: Aromatic hydroxylation of ellipticine in rats: lack of an NIH shift. Biomed. Mass Spectromet. 3, 335–339 (1976)
Ross, W., Glaubiger, D., Kohn, K.W.: Protein-associated DNA breaks in cells treated with adriamycin or ellipticine. Biochim. Biophys. Acta 519, 23–30 (1978)
Snyder, A.L., Kann, H.E., Jr., Kohn, K.W.: Inhibition of the processing of ribosomal precursor RNA by intercalating agents. J. Mol. Biol. 58, 555–565 (1971)
Sorace, R.A., Sheid, B.: Anti-tumor effects of DNA-ellipticine and DNA-ellipticine: daunomycin on the L1210(A) leukemia. Fed. Proc. 36, 335 (1977)
Svoboda, G., Poore, G.A., Montfort, M.L.: Isolation of the alkaloids and study of the antitumor properties of 9-methoxyellipticine. J. Pharm. Sci. 57, 1720–1725 (1968)
Tobey, R.A.: A simple, rapid technique for determination of the effects of chemotherapeutic agents on mammalian cell-cycle traverse. Cancer Res. 32, 309–316 (1972)
Wang, J.C.: The degree of unwinding of the DNA helix by ethidium. I. Titration of twisted PM2 DNA molecules in alkaline cesium chloride density gradients. J. Mol. Biol. 89, 783 (1974)
Waring, M.: Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: evidence from molecular models involving intercalation. J. Mol. Biol. 54, 247 (1970)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Kohn, K.W., Ross, W.E., Glaubiger, D. (1979). Ellipticine. In: Hahn, F.E. (eds) Mechanism of Action of Antieukaryotic and Antiviral Compounds. Antibiotics, vol 5 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46407-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-46407-2_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46409-6
Online ISBN: 978-3-642-46407-2
eBook Packages: Springer Book Archive